Centessa Pharmaceuticals plc - American Depositary Shares (CNTA)
15.75
-0.54 (-3.31%)
Centessa Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of innovative medicines to address unmet medical needs
The company's unique asset-centric approach leverages a diverse portfolio of drug candidates, targeting various diseases and conditions, particularly in areas such as oncology, immunology, and rare diseases. Centessa collaborates with leading scientific experts and employs advanced technologies to advance its therapeutic programs through clinical trials, aiming to bring transformative treatments to patients worldwide.

Via Benzinga · March 5, 2025

Via Benzinga · January 24, 2025

Via Benzinga · November 25, 2024

Via Benzinga · November 21, 2024

Centessa Pharmaceuticals revealed promising interim Phase 1 trial results for ORX750, demonstrating significant improvements in sleep latency for acutely sleep-deprived healthy volunteers. The company plans to advance ORX750 into Phase 2 studies targeting narcolepsy and idiopathic hypersomnia in Q4 2024.
Via Benzinga · September 10, 2024

Via Benzinga · September 10, 2024

The company tested a potential narcolepsy treatment in healthy, but sleep-deprived, volunteers.
Via Investor's Business Daily · September 10, 2024

CNTA stock results show that Centessa Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 13, 2024

CNTA stock results show that Centessa Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 13, 2024

CNTA stock results show that Centessa Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 28, 2024

With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas.
Via InvestorPlace · March 18, 2024

Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results.
Via Benzinga · February 9, 2024

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 100 points on Friday. Shares of SPS Commerce, Inc. (NASDAQ: SPSC) rose sharply during Friday’s session following upbeat results.
Via Benzinga · February 9, 2024

Via Benzinga · November 27, 2023

Via Benzinga · July 13, 2023

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.
Via Benzinga · July 12, 2023

U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here are some big stocks bucking the trend and recording gains in today’s session.
Via Benzinga · October 26, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via Benzinga · July 12, 2023

Pancreatic Cancer Trials & New Treatments Receiving Increased Funding as Incidences of Cancer Grows
Via News Direct · June 23, 2023

Via Benzinga · June 21, 2023

Via Benzinga · June 12, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via Benzinga · November 22, 2022

Via Benzinga · March 17, 2023